Population analysis of antiviral T cell responses using MHC class I-peptide tetramers

Clinical and Experimental Immunology

Volumn 134, Issue 1, 2003, Pages 9-12

  Komatsu, H ^a   Sierro, S ^a   Cuero, A V ^a   Klenerman, P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CD8+T lymphocyte; CMV; Memory; MHC class I; Tetramer

Indexed keywords

ASPARAGINYLLEUCYLVALYLPROLYLMETHIONYLVALYLALANYLTHREONYLVALINE; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE DERIVATIVE; TETRAMER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD VOLUME; CELLULAR IMMUNITY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFANT; MASS SCREENING; NONHUMAN; NORMAL HUMAN; PEPTIDE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COLORING AGENTS; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS INFECTIONS; EDETIC ACID; EPITOPES; EPSTEIN-BARR VIRUS INFECTIONS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HLA-A2 ANTIGEN; HUMANS; IMMUNOLOGIC MEMORY; INFANT; MASS SCREENING; MIDDLE AGED; VIRUS DISEASES;

EID: 0141539465     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02266.x     Document Type: Article

References (27)

1. Masopust D, Vezys V, Marzo A et al. Preferential localisation of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413-7.
2. + T cells vary in differentiation phenotype in different persistent virus infections. Nature Med 2002; 8:379-85.
3. Klenerman P, Cerunulo V, Dunbar P. Tracking T cells with tetramers: new tales from new tools. Nature Rev Immunol 2002; 2:263-72.
4. + memory T cells. J Exp Med 1997; 186:859-65.
5. Altman J, Moss PAH, Goulder P et al. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals. Science 1996; 274:94-6.
6. + lymphocytes using class I peptide tetramers. Rev Med Virol 2001; 11:11-22.
7. Ogg G, Jin X, Bonhoeffer S et al. Quantitation of HIV-1 specific CTL and plasma load of HIV-1. Science 1998; 279:2103-6.
8. Lechner F, Wong DK, Dunbar PR et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000; 191:1499-512.
9. Wills MR, Carmichael AJ, Mynard K et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996; 70:7569-79.
10. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol 1995; 155:5046-56.
11. Gillespie GM, Wills MR, Appay V et al. Functional heterogeneity and high frequencies of cytomegalovirus-specific. J Virol 2000; 74:8140-50.
12. + T cells over time. J Immunol 2003; 170:2022-9.
13. Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ. Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L (lo) memory-effector pool during latent murine cytomegalovirus infection of the lungs. J virol 2000; 74:11495-503.
14. Khan N, Shariff NCM, Bruton R et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169:1984-92.
15. Olsson J, Wikby A, Johansson B et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000; 121:187-201.
16. + cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus. J Infect Dis 2001; 183:835-43.
17. Mocarski E, Courcelle C. Cytomegaloviruses and their replication. In: Knipe D, Howley P, eds. Fields virology. Philadelphia, PA: Lippincott, Williams and Wilkins, 2001:2629-73.
18. Henry S, Hamilton J. Detection of murine cytomegalovirus immediate early 1 transcripts in the spleens of latently infected mice. J Infect Dis 1993; 167:950-4.
19. Hummel M, Zhang Z, Yan S et al. Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J Virol 2001; 75:4814-22.
20. Grzimek N, Dreis D, Schmalz S et al. Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J Virol 2001; 75:2692-705.
21. + T cells during the primary immune response to EBV in vivo. J Exp Med 1998; 187:1395-402.
22. + T cell memory in vivo. Eur J Immunol 1998; 28:4382-90.
23. Dunbar P, Ogg G, Chen J et al. Direct isolation, phenotyping and cloning of low frequency antigen-specific CTL from peripheral blood. Current Biol 1998; 8:413-6.
24. Luzyanina T, Engelborghs KES, Klenerman P, Bocharov G. Low level viral persistence after infection with LCMV: a quantitative insight through numerical bifurcation analysis. Math Biosci 2001; 173:1-23.
25. Ogg GS, Jin X, Bonhoeffer S et al. Decay kinetics of human immuno-deficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol 1999; 73:797-800.
26. Dunbar PR, Smith CL, Chao D et al. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J Immunol 2000; 165:6644-52.
27. Li CR, Greenberg PD, Gilbert MJ et al. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83:1971-9.